Ortivus AB ser. B (ORTI-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ortivus AB ser. B (ORTI-B) has a cash flow conversion efficiency ratio of -0.529x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.86 Million ≈ $-1.28 Million USD) by net assets (Skr22.41 Million ≈ $2.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ortivus AB ser. B - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Ortivus AB ser. B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Ortivus AB ser. B total liabilities for a breakdown of total debt and financial obligations.
Ortivus AB ser. B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ortivus AB ser. B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Herkules S.A.
WAR:HRS
|
0.023x |
|
Akritas S.A
AT:AKRIT
|
-0.137x |
|
Asturiana de Laminados S.A.
MC:ELZ
|
0.921x |
|
Gaming Corps AB
ST:GCOR
|
-0.239x |
|
Churchill Capital Corp IX Warrant
NASDAQ:CCIXW
|
-0.001x |
|
Maming Enam Sembilan Mineral Tbk PT
JK:AKSI
|
-0.008x |
|
Tong Hua Holding Public Company Limited
BK:TH
|
0.002x |
|
Ata Gayrimenkul Yatirim Ortakligi AS
IS:ATAGY
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Ortivus AB ser. B (2003–2025)
The table below shows the annual cash flow conversion efficiency of Ortivus AB ser. B from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Ortivus AB ser. B market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr22.41 Million ≈ $2.41 Million |
Skr-25.24 Million ≈ $-2.72 Million |
-1.126x | -182.77% |
| 2024-12-31 | Skr-7.17 Million ≈ $-771.07K |
Skr-9.75 Million ≈ $-1.05 Million |
1.360x | +7869.33% |
| 2023-12-31 | Skr17.30 Million ≈ $1.86 Million |
Skr-303.00K ≈ $-32.61K |
-0.018x | +90.98% |
| 2022-12-31 | Skr35.44 Million ≈ $3.81 Million |
Skr-6.88 Million ≈ $-740.18K |
-0.194x | -173.52% |
| 2021-12-31 | Skr29.44 Million ≈ $3.17 Million |
Skr7.77 Million ≈ $836.61K |
0.264x | -72.11% |
| 2020-12-31 | Skr19.68 Million ≈ $2.12 Million |
Skr18.63 Million ≈ $2.00 Million |
0.947x | +336.12% |
| 2019-12-31 | Skr8.75 Million ≈ $942.07K |
Skr-3.51 Million ≈ $-377.73K |
-0.401x | -71.47% |
| 2018-12-31 | Skr2.18 Million ≈ $234.71K |
Skr-510.00K ≈ $-54.88K |
-0.234x | +69.43% |
| 2017-12-31 | Skr15.55 Million ≈ $1.67 Million |
Skr-11.90 Million ≈ $-1.28 Million |
-0.765x | -180.94% |
| 2016-12-31 | Skr5.22 Million ≈ $561.97K |
Skr4.93 Million ≈ $531.08K |
0.945x | +444.95% |
| 2015-12-31 | Skr12.36 Million ≈ $1.33 Million |
Skr-3.39 Million ≈ $-364.50K |
-0.274x | -116.60% |
| 2014-12-31 | Skr19.35 Million ≈ $2.08 Million |
Skr31.93 Million ≈ $3.44 Million |
1.651x | +498.55% |
| 2013-12-31 | Skr17.21 Million ≈ $1.85 Million |
Skr-7.13 Million ≈ $-767.09K |
-0.414x | -244.38% |
| 2012-12-31 | Skr31.19 Million ≈ $3.36 Million |
Skr8.95 Million ≈ $962.73K |
0.287x | +195.85% |
| 2011-12-31 | Skr29.03 Million ≈ $3.12 Million |
Skr-8.69 Million ≈ $-934.97K |
-0.299x | +24.94% |
| 2010-12-31 | Skr66.95 Million ≈ $7.20 Million |
Skr-26.69 Million ≈ $-2.87 Million |
-0.399x | -235.70% |
| 2009-12-31 | Skr84.63 Million ≈ $9.11 Million |
Skr-10.05 Million ≈ $-1.08 Million |
-0.119x | +33.33% |
| 2008-12-31 | Skr106.52 Million ≈ $11.46 Million |
Skr-18.98 Million ≈ $-2.04 Million |
-0.178x | -1980.44% |
| 2007-12-31 | Skr163.02 Million ≈ $17.54 Million |
Skr-1.40 Million ≈ $-150.23K |
-0.009x | +95.21% |
| 2006-12-31 | Skr226.03 Million ≈ $24.32 Million |
Skr-40.42 Million ≈ $-4.35 Million |
-0.179x | -126.19% |
| 2005-12-31 | Skr229.72 Million ≈ $24.72 Million |
Skr-18.16 Million ≈ $-1.95 Million |
-0.079x | -131.94% |
| 2004-12-31 | Skr224.47 Million ≈ $24.16 Million |
Skr55.57 Million ≈ $5.98 Million |
0.248x | -8.52% |
| 2003-12-31 | Skr225.09 Million ≈ $24.22 Million |
Skr60.91 Million ≈ $6.55 Million |
0.271x | -- |
About Ortivus AB ser. B
Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMe… Read more